MBCOF (Marvel Biosciences) Current Accrued Expense: $0.24 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MBCOF Marvel Biosciences Corp MBCOF
34 GF Score
Price $0.10
! 1 Warning Sign
View Full Analysis

What is Marvel Biosciences Current Accrued Expense?

Marvel Biosciences MBCOF -10.36% 34 Current Accrued Expense is $0.24 Mil as of Apr. 2026. GuruFocus rates MBCOF with a GF Score™ of 34/100. The stock has 1 warning sign investors should review.

Marvel Biosciences's Current Accrued Expense for the quarter that ended in Apr. 2026 was $0.24 Mil.

Marvel Biosciences's quarterly Current Accrued Expense increased from Oct. 2025 ($0.30 Mil) to Jan. 2026 ($0.31 Mil) but then declined from Jan. 2026 ($0.31 Mil) to Apr. 2026 ($0.24 Mil).

Marvel Biosciences's annual Current Accrued Expense increased from Jul. 2023 ($0.03 Mil) to Jul. 2024 ($0.19 Mil) and increased from Jul. 2024 ($0.19 Mil) to Jul. 2025 ($0.38 Mil).

Marvel Biosciences Current Accrued Expense Related Terms

Marvel Biosciences Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Marvel Biosciences's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marvel Biosciences Current Accrued Expense Chart

Marvel Biosciences Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Current Accrued Expense
Get a 7-Day Free Trial 0.00 0.00 0.03 0.19 0.38

Marvel Biosciences Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.38 0.30 0.31 0.24
MBCOF
34GF Score
Marvel Biosciences Corp MBCOF
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Marvel Biosciences Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $0.24 Mil mean?
Marvel Biosciences (MBCOF) has a Current Accrued Expense of $0.24 Mil as of Apr. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Marvel Biosciences and its competitors.
Is Marvel Biosciences' Current Accrued Expense too high?
Marvel Biosciences' current Current Accrued Expense is $0.24 Mil. Overall, Marvel Biosciences has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Marvel Biosciences' Current Accrued Expense compare to VRTX and REGN?
Marvel Biosciences' Current Accrued Expense of $0.24 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Biotechnology company?
A good Current Accrued Expense depends on the Biotechnology industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Marvel Biosciences and its competitors. Marvel Biosciences's current Current Accrued Expense is $0.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Marvel Biosciences stock overvalued right now?
Marvel Biosciences (MBCOF) has a current Current Accrued Expense of $0.24 Mil. The current Current Accrued Expense is $0.24 Mil. Marvel Biosciences' overall GF Score™ is 34/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Marvel Biosciences (MBCOF), the current Current Accrued Expense is $0.24 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Marvel Biosciences Business Description

Other Exchanges MRVL:Canada
Address 505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2
Marvel Biosciences Corp is a biotechnology company incorporated in Canada. The Company is currently a pre-clinical stage pharmaceutical development company that utilizes a drug redevelopment approach to identify and evaluate potential therapeutic compounds. Its activities mainly involve scientific research and pre-clinical studies aimed at determining viable active compounds for further drug development.
34GF Score

Get the complete analysis for MBCOF

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price